Summit Therapeutics
SMMT
#1547
Rank
โ‚ฌ11.59 B
Marketcap
14,95ย โ‚ฌ
Share price
-3.79%
Change (1 day)
-19.25%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of December 2025 : โ‚ฌ0.57 Billion

According to Summit Therapeutics 's latest financial reports the company has โ‚ฌ0.57 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2014 to 2020)

Net assets by year

Year Net assets Change
2025-12-31$โ‚ฌ0.56 B50.13%
2024-12-31$โ‚ฌ0.37 B431.55%
2023-12-31$โ‚ฌ70.28 M-40.48%
2022-12-31$โ‚ฌ0.11 B60.56%
2021-12-31$โ‚ฌ73.53 M13.84%
2020-12-31$โ‚ฌ64.59 M
2019-01-31$โ‚ฌ48.56 M-1450.81%
2018-01-31$-โ‚ฌ3.6 Million-29.46%
2017-01-31$-โ‚ฌ5.1 Million-124.1%
2016-01-31$โ‚ฌ21.14 M-30.21%
2015-01-31$โ‚ฌ30.29 M422.93%
2014-01-31$โ‚ฌ5.79 M10.49%
2013-01-31$โ‚ฌ5.24 M16.08%
2012-01-31$โ‚ฌ4.51 M-33.46%
2011-01-31$โ‚ฌ6.78 M-55.55%
2010-01-31$โ‚ฌ15.27 M12.3%
2009-01-31$โ‚ฌ13.59 M-81.22%
2008-01-31$โ‚ฌ72.41 M19.75%
2007-01-31$โ‚ฌ60.47 M76.71%
2006-01-31$โ‚ฌ34.22 M-10.63%
2005-01-31$โ‚ฌ38.29 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ0.98 B 73.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ0.19 B-66.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ76.03 M-86.68%๐Ÿ‡บ๐Ÿ‡ธ USA